Slynd birth control drugmaker Exeltis hit with FDA letter over misleading social media promotion
A sponsored social media post for Slynd birth control is the latest ad offender in the eyes of the FDA’s promotions watchdog. The Office of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
